Ajooni Biotech, a leading animal healthcare, and animal feed company, plans to raise ₹29 crores through its rights issue. The rights issue will open for subscription on Wednesday. The funds raised through the issue will be used by the company for its expansion plans, market expansion, and for meeting general corporate objectives.
The rights issue priced at Rs 36 per share is available at a 30 percent discount to Tuesday's closing price. The rights issue will close on December 15. The company launched its IPO on the NSE Emerge platform in December 2017 and got shifted to the main board of NSE in May. The dairy-agri-oriented company will issue 4,83,60,313 fully paid-up equity shares.
Also Read: Layoffs: Retrenchment continues in companies, now PepsiCo is planning to sack hundreds of employees
After spending five days in jail, a Gurugram court granted bail to YouTuber and Bigg Boss OTT 2 w
Former CM Bhupinder Singh Hooda reached his house on Sunday after his mother Savita revealed that
Monsoon rains have wreaked havoc in many states of North India. Delhi, Haryana, Punjab, and Himac
Covid-19 in India: 228 new cases of corona in India amid the panic of BF7, active cases reduced
Coronavirus has wreaked havoc in many countries including China, but in India, its speed has been
An incident during the promotional event for Prabhas's upcoming film 'The Raja Saab' in Hyderabad
India Global Forum: India's focus on climate action is on prudent consumption: Bhupendra Yadav
Union Environment Minister Bhupendra Yadav on Monday said that India is determined to be part of
The way the Ukraine war has brought forth the problem of an energy crisis in the whole world, the
Bhool Bhulaiyaa 3 is all set to rock the theatres this Diwali. The film's star cast is busy promo
In the past few days, gold and silver have been setting new records every day. However, today, af
Ram Rahim's parole is over. Before returning to jail, Ram Rahim openly praised PM Narendra Modi
